BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33046048
Number of visits today
6412
Number of downloads
16241658
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: White CW, Kilpatrick LE, Dale N, Abhayawardana RS, Dekkers S, Stocks MJ, Pfleger KDG, Hill SJ. CXCL17 is an endogenous inhibitor of CXCR4 via a novel mechanism of action.. [DOI: 10.1101/2021.07.05.451109] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Hashemi SF, Khorramdelazad H. The cryptic role of CXCL17/CXCR8 axis in the pathogenesis of cancers: a review of the latest evidence. J Cell Commun Signal 2022. [DOI: 10.1007/s12079-022-00699-7] [Reference Citation Analysis]
2 Harms M, Hayn M, Zech F, Kirchhoff F, Münch J. Endogenous Peptide Inhibitors of HIV Entry. Advances in Experimental Medicine and Biology 2022. [DOI: 10.1007/978-981-16-8702-0_5] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345